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Materials and Methods: Fourteen patients treated atour facility with 
passively scattered proton beams were selected. Aperture areas 
ranged from ~3 to ~35 cm2. Aperture sizes < 3 cm2 were not 
considered in this study because aperture scattering effects might 
outweigh effects from patient heterogeneities. Dose distributions 
predicted by our pencil beam (PB) algorithm were verified against MC 
dose calculations using TOPAS—a TOol for PArticle Simulation layered 
on top of GEANT4. Open field dosimetry was corrected based on the 
clinical guidelines for small fields to consider aperture scattering and 
dose equilibrium. DVHs were analyzed and differences in the dose to 
the 50% of the GTV (D50) were assessed on a field-by-field basis. We 
developed a simple and fast methodology to quantify the tissue 
inhomogeneity traversed by a single beam using a heterogeneity index 
(HI). The implementation was based on the dose calculation approach 
taken by our PB algorithm. Finally, we evaluated the potential 
correlation between the errors made by our PB algorithm in D50 for 
each field and the level of tissue heterogeneity traversed by the 
proton beam given by HI. 
Results: Discrepancies up to 5.4% were found in D50 ([D50PB—D50MC]/ 
D50MC). The discrepancies found for each field exhibited a strong 
correlation to their associated HI-values (Spearman's ρ = 0.8, p 
<0.0001); the higher the level of tissue heterogeneities for a 
particular field, the larger the dosimetric error by the analytical 
algorithm. With the established correlation a threshold for HI could be 
set by choosing a tolerance level; requiring an absolute difference for 
D50 < 2.5% for clinical routines suggests recalculation ofpatient 
treatments for HIt >> 1.7. 
 
  
Conclusions: The HI as defined in this study appeared to be a good 
indicator for theaccuracy of proton field delivery in terms of GTV 
prescription dose coverage. Each HI-value was obtained in less than 3 
minutes allowing the implementation of this methodology in the 
clinical routine. For HI-values exceeding the threshold, either a 
change in beam direction (if feasible) or a recalculationof the dose 
with Monte Carlo would be highly recommended.  
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Purpose/Objective: To validate experimentally a GATE/GEANT4-
based(G4) Monte Carlo (MC) model in heterogeneous media for 
dedicated pencil beam scanning in proton therapy. Comparisons 
between measurements and MC simulations using G4 and PENELOPE-
proton are presented. A comparison against analytical modeling from 
commercial TPS is also investigated. This work evaluates the impact 
of heterogeneities on range prediction, beam shape and depth dose 
changes. 
Materials and Methods: The MC model for pencil beam based on G4 
has been validated in water and PMMA phantoms (Grevillot et al Phys. 
Med. Biol.(2011)) reproducing pristine Bragg peaks for a series of 
individual energies (from 100 to 226.7 MeV) with 0.7 mm range and 
0.2 mm spot size accuracy. The same optical model was implemented 
in PENELOPE-proton. In order to validate the beam model in 
heterogeneous media, phantoms made of stacked slabs with different 
densities and known compositions were used. Two experimental test 
cases including solid water (SW), lung (LN-300) and bone (SB3) tissue-
equivalent material were investigated. Depth-dose distributions for a 
monoenergetic single spot and 10x10cm² composite fields were 
measured using Gafchromic EBT3 films and the ionization chamber 
(IC) PPC05 in all configurations. To measure accurately the Bragg peak 
position, a stack of films of 2x2cm² was inserted in the last 
centimeter of the proton range. 
Results: Figure 1 shows results for one heterogeneous configuration. 
All doses-to-medium were converted to dose to water using stopping 
power ratios. Dose distributions were arbitrarily normalized in the 
middle of the second SW region. Bragg peak positions are reproduced 
by MC simulations within 1mm in both configurations (Table 1). IC 
measurements, G4 (binary-cascade) and PENELOPE-proton simulations 
are within 2%/2 mm. Point-to-point mean difference of 1.2% is 
observed between G4 (precompound) and measurement in the first 15 
cm of the phantom and increased to 7.2% after bone insert until 
286.5mm depth. In lung and bone slabs, EBT3 films and G4 binary-
cascade are inagreement within 0.77% while a mean point-to-point 
difference up to 1.26% is observed with G4 precompound model. The 
uncertainty (1σ) on EBT3 films was evaluated to be at 2.75% which 
included readout process and dose calibration against IC (TRS-398). A 




Conclusions: The Bragg peak position is predicted with 1mm precision 
for all MC simulations, even though ionization potential values for 
phantom slabs were calculated using classical additive rules. G4/GATE 
beam model reproduce depth-dose behavior of proton transport 
regarding both IC and EBT3 measurement in heterogeneities. 
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Purpose/Objective: Currently, pencil beam dose calculation 
algorithms are commonly used in treatment planning for radiotherapy 
with protons. These algorithms are of limited accuracy in some 
situations such as patient heterogeneities, which could be overcome 
when using Monte Carlo (MC) methods. However, MC suffers from long 
